Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects

被引：1175

作者：

Evans, WE

McLeod, HL

机构：

[1] St Jude Childrens Res Hosp, Memphis, TN 38101 USA

[2] Univ Tennessee, Coll Pharm, Memphis, TN USA

[3] Univ Tennessee, Coll Med, Memphis, TN USA

[4] Washington Univ, Sch Med, St Louis, MO USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 06期

关键词：

D O I：

10.1056/NEJMra020526

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：538 / 549

页数：12

共 96 条

[1] MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia [J].

Abbott, GW ;

Sesti, F ;

Splawski, I ;

Buck, ME ;

Lehmann, WH ;

Timothy, KW ;

Keating, MT ;

Goldstein, SAN .

CELL, 1999, 97 (02) :175-187

[2] MDR1 pharmacogenetics:: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity [J].

Ameyaw, MM ;

Regateiro, F ;

Li, T ;

Liu, XH ;

Tariq, M ;

Mobarek, A ;

Thornton, N ;

Folayan, GO ;

Githang'a, J ;

Indalo, A ;

Ofori-Adjei, D ;

Price-Evans, DA ;

McLeod, HL .

PHARMACOGENETICS, 2001, 11 (03) :217-221

[3] Pharmacogenetic prediction of clozapine response [J].

Arranz, MJ ;

Munro, J ;

Birkett, J ;

Bolonna, A ;

Mancama, D ;

Sodhi, M ;

Lesch, KP ;

Meyer, JFW ;

Sham, P ;

Collier, DA ;

Murray, RM ;

Kerwin, RW .

LANCET, 2000, 355 (9215) :1615-1616

[4] Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy [J].

Ballantyne, CM ;

Herd, JA ;

Stein, EA ;

Ferlic, LL ;

Dunn, JK ;

Gotto, AM ;

Marian, AJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (05) :1572-1578

[5] Association of the MscI polymorphism of the dopamine D3 receptor gene with tardive dyskinesia in schizophrenia [J].

Basile, VS ;

Masellis, M ;

Badri, F ;

Paterson, AD ;

Meltzer, HY ;

Lieberman, JA ;

Potkin, SG ;

Macciardi, F ;

Kennedy, JL .

NEUROPSYCHOPHARMACOLOGY, 1999, 21 (01) :17-27

[6] Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine [J].

Black, AJ ;

McLeod, HL ;

Capell, HA ;

Powrie, RH ;

Matowe, LK ;

Pritchard, SC ;

Collie-Duguid, ESR ;

Reid, DM .

ANNALS OF INTERNAL MEDICINE, 1998, 129 (09) :716-718

[7] A family of drug transporters: The multidrug resistance-associated proteins [J].

Borst, P ;

Evers, R ;

Kool, M ;

Wijnholds, J .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302

[8] Pharmacogenetics of the human drug-transporter gene MDR1:: impact of polymorphisms on pharmacotherapy [J].

Brinkmann, U ;

Roots, I ;

Eichelbaum, M .

DRUG DISCOVERY TODAY, 2001, 6 (16) :835-839

[9]

Cargill M, 2000, Pharmacogenomics, V1, P27, DOI 10.1517/14622416.1.1.27

[10] ENZYMATIC DEFICIENCY IN PRIMAQUINE-SENSITIVE ERYTHROCYTES [J].

CARSON, PE ;

FLANAGAN, CL ;

ICKES, CE ;

ALVING, AS .

SCIENCE, 1956, 124 (3220) :484-485

← 1 2 3 4 5 6 7 8 9 10 →